Cytotoxic Lymphocyte Maturation Factor

The present invention relates to a monoclonal or polyclonal antibody directed to an epitope of a cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JEFFREY DAVID HULMES, ALVIN SETH STERN, FRANK JOHN PODLASKI, MAURICE KENT GATELY, YUING EUGENE PAN, ULRICH ANDREAS GUBLER, RICHARD ANTHONY CHIZZONITE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a monoclonal or polyclonal antibody directed to an epitope of a cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to hybridoma cell lines secreting said monoclonal antibody, to processes for the preparation of the said antibodies and to the use of said antibodies for the purification and detection of CLMF protein and for the selective blockade of proliferation and activation of cytotoxic T cells.